Mounjaro injection site: what most people get wrong before they start

The myth: it only works properly in the stomach

Spend any time in weight-loss forums and you'll find firm opinions that the abdomen gives better absorption than the thigh or upper arm. It is an understandable assumption (GLP-1 medicines have historically been associated with abdominal injections) but it is not supported by the licensed guidance for tirzepatide, the active ingredient in Mounjaro.

The Mounjaro Summary of Product Characteristics, accessible via the Mounjaro SmPC on the eMC, lists the abdomen, thigh, and outer upper arm as equivalent injection sites. No site is ranked above another for efficacy. What the evidence does support is rotating between sites: using the same small patch of skin week after week can lead to lipohypertrophy, a lumpy thickening of fatty tissue that slows absorption and is entirely preventable with simple rotation.

So if you've been injecting in the same spot for weeks because someone online said the abdomen is the only place that works, it is worth varying your sites. Your prescriber or the Patient Information Leaflet that comes with your pen will walk you through the practical detail; the short version is that a few centimetres' difference each week keeps the tissue healthy. For a fuller picture of how tirzepatide works as a medicine, the Mounjaro overview on our treatment page covers the mechanism and licensed indications in plain terms.

How to choose between the three sites on any given week

Practically speaking, each of the three locations suits different circumstances, and our guidance on Mounjaro sites covers the key considerations for each location. The abdomen (specifically the area to the side of the navel, avoiding the navel itself) tends to be easiest to reach and the most consistent choice for self-injection. The outer thigh is useful when the abdomen is uncomfortable, for example after surgery or if there is localised soreness. The outer upper arm is a common choice when someone else is administering the injection, since it is harder to reach and steady on yourself.

There are a few spots to avoid regardless of which site you choose: anywhere with broken skin, bruising, scarring, or existing injection-site reactions. Insulin users should also keep Mounjaro injections at least three centimetres away from any insulin injection site used that day, though the two medicines should never be mixed in the same injection.

The NHS guidance on weight-management injections, published by NHS England, reinforces that site rotation is standard practice across all subcutaneous injectable weight-management medicines, and for good reason: it is one of the simplest things you can do to make the weekly injection more comfortable over months of treatment.

Injection-site reactions: what is normal and what to watch for

Mild redness, slight swelling, or a brief stinging sensation at the injection site are listed among the common side effects of Mounjaro, and our page on Mounjaro jab sites explains what to expect at each location. Most people find these settle within a few hours and become less noticeable as treatment continues. Arriving at the injection with a pen that has been sitting at room temperature for a short while (rather than injecting straight from the fridge) is a tip many people find reduces discomfort, though for the exact permitted room-temperature window, you should check the Patient Information Leaflet rather than rely on secondhand advice, since the guidance is specific.

Beyond ordinary site reactions, a small number of people experience more persistent localised symptoms. Any lump, hardness, or skin change that does not resolve, or any sign of an allergic reaction such as widespread itching or difficulty breathing, should be reported to your prescriber promptly. Suspected side effects from any medicine (including at the injection site) can also be logged directly with the MHRA via the Yellow Card scheme, which exists precisely so that post-market safety data continues to be collected.

If you have questions about technique that your pen's instructions do not fully cover, our support team is available seven days a week to help, or you can review common questions on our FAQs page.

Getting started: what this means for a new prescription

Understanding injection sites matters most in the first week, when everything is new. The KwikPen makes the mechanical part straightforward, there is no assembly, no drawing up fluid, and the needle is hidden within the device if that is a concern. The pen delivers one pre-set dose each time, and each pen contains four weekly doses, so you will use the same pen for a full month before moving to a new one.

Mounjaro is a prescription-only medicine; a prescriber assesses your full medical history before any treatment begins, which means questions about your specific anatomy, any skin conditions at the injection sites, or anything else that makes a standard site unsuitable can be factored in at that stage. Those starting at the 2.5mg dose (the standard starting point under the licensed schedule) will typically find the first injection the most daunting and each subsequent one considerably less so.

If you are wondering whether Mounjaro is clinically suitable for you, the starting point is a consultation rather than a purchase, and you can find full prescribing and safety information on the Mounjaro section of our website. Our free consultation is reviewed the same day by a GPhC-registered prescriber; eligibility depends on your health history, not just your BMI. There is a broader look at what affects suitability on our weight-loss treatments overview, and if you want to understand how Mounjaro compares with other options, our Mounjaro comparison page sets out the differences in plain terms, and if you want to understand the people reviewing consultations, our clinical lead's profile is on the clinical team page.